Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Income from Continuing Operations: 2019-2025

Historic Income from Continuing Operations for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to $16.8 million.

  • Burning Rock Biotech's Income from Continuing Operations fell 91.19% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 106.92%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • As of Q3 2025, Burning Rock Biotech's Income from Continuing Operations stood at $16.8 million, which was up 182.30% from -$20.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Income from Continuing Operations high stood at $614.6 million for Q4 2022, and its period low was -$231.4 million during Q3 2022.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$20.5 million (2025), whereas its average is $327,909.
  • Examining YoY changes over the last 5 years, Burning Rock Biotech's Income from Continuing Operations showed a top increase of 1,609.78% in 2022 and a maximum decrease of 775.17% in 2022.
  • Burning Rock Biotech's Income from Continuing Operations (Quarterly) stood at -$40.7 million in 2021, then skyrocketed by 1,609.78% to $614.6 million in 2022, then tumbled by 35.33% to $397.4 million in 2023, then tumbled by 102.07% to -$8.2 million in 2024, then slumped by 91.19% to $16.8 million in 2025.
  • Its Income from Continuing Operations was $16.8 million in Q3 2025, compared to -$20.5 million in Q2 2025 and -$13.1 million in Q1 2025.